These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32368073)

  • 1. Metabolic Syndrome for Cardiovascular Disease Morbidity and Mortality Among General Japanese People: A Mini Review.
    Watanabe J; Kotani K
    Vasc Health Risk Manag; 2020; 16():149-155. PubMed ID: 32368073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between metabolic syndrome and mortality from cardiovascular disease in Japanese general population, findings on overweight and non-overweight individuals. Ibaraki Prefectural Health Study.
    Irie F; Iso H; Noda H; Sairenchi T; Otaka E; Yamagishi K; Doi M; Izumi Y; Ota H
    Circ J; 2009 Sep; 73(9):1635-42. PubMed ID: 19590142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proposed criteria for metabolic syndrome in Japanese based on prospective evidence: the Hisayama study.
    Doi Y; Ninomiya T; Hata J; Yonemoto K; Arima H; Kubo M; Tanizaki Y; Iwase M; Iida M; Kiyohara Y
    Stroke; 2009 Apr; 40(4):1187-94. PubMed ID: 19265058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome and all-cause mortality, cardiac events, and cardiovascular events: a follow-up study in 25,471 young- and middle-aged Japanese men.
    Kondo T; Osugi S; Shimokata K; Honjo H; Morita Y; Yamashita K; Maeda K; Muramatsu T; Shintani S; Matsushita K; Murohara T
    Eur J Cardiovasc Prev Rehabil; 2011 Aug; 18(4):574-80. PubMed ID: 21450628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of smoking and metabolic syndrome for incidence of cardiovascular disease--comparison of relative contribution in urban Japanese population: the Suita study.
    Higashiyama A; Okamura T; Ono Y; Watanabe M; Kokubo Y; Okayama A
    Circ J; 2009 Dec; 73(12):2258-63. PubMed ID: 19838005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LV Mass as a Predictor of CVD Events in Older Adults With and Without Metabolic Syndrome and Diabetes.
    Hoang K; Zhao Y; Gardin JM; Carnethon M; Mukamal K; Yanez D; Wong ND
    JACC Cardiovasc Imaging; 2015 Sep; 8(9):1007-1015. PubMed ID: 26319502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of a low ankle-brachial index with all-cause mortality and cardiovascular mortality in Chinese patients with metabolic syndrome after a 6-year follow-up: a Chinese prospective cohort study.
    Cang Y; Li J; Li YM; Zhou Y; Wu YZ; Li XK; Wang CF; Yang HY; Xu YW
    Intern Med; 2012; 51(20):2847-56. PubMed ID: 23064557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort.
    Guembe MJ; Fernandez-Lazaro CI; Sayon-Orea C; Toledo E; Moreno-Iribas C;
    Cardiovasc Diabetol; 2020 Nov; 19(1):195. PubMed ID: 33222691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of New Criteria for Metabolic Syndrome Optimized for Prediction of Cardiovascular Diseases in Japanese.
    Yamazaki Y; Fujihara K; Sato T; Harada Yamada M; Yaguchi Y; Matsubayashi Y; Yamada T; Kodama S; Kato K; Shimano H; Sone H
    J Atheroscler Thromb; 2024 Apr; 31(4):382-395. PubMed ID: 37981330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of age and gender on the prevalence and prognostic importance of the metabolic syndrome and its components in Europeans. The MORGAM Prospective Cohort Project.
    Vishram JK; Borglykke A; Andreasen AH; Jeppesen J; Ibsen H; Jørgensen T; Palmieri L; Giampaoli S; Donfrancesco C; Kee F; Mancia G; Cesana G; Kuulasmaa K; Salomaa V; Sans S; Ferrieres J; Dallongeville J; Söderberg S; Arveiler D; Wagner A; Tunstall-Pedoe H; Drygas W; Olsen MH;
    PLoS One; 2014; 9(9):e107294. PubMed ID: 25244618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of metabolic syndrome on the development of cardiovascular disease in a general Japanese population: the Hisayama study.
    Ninomiya T; Kubo M; Doi Y; Yonemoto K; Tanizaki Y; Rahman M; Arima H; Tsuryuya K; Iida M; Kiyohara Y
    Stroke; 2007 Jul; 38(7):2063-9. PubMed ID: 17525396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome and all-cause and cardiovascular disease mortality: Japan Public Health Center-based Prospective (JPHC) Study.
    Saito I; Iso H; Kokubo Y; Inoue M; Tsugane S
    Circ J; 2009 May; 73(5):878-84. PubMed ID: 19282609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of Metabolic Syndrome and its Components With Mortality in the Elderly: A Cohort Study of 73,547 Taiwanese Adults.
    Yen YF; Hu HY; Lin IF; Lai YJ; Su VY; Pan SW; Ting WY; Su WJ
    Medicine (Baltimore); 2015 Jun; 94(23):e956. PubMed ID: 26061328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in asian diabetic patients? Analysis from the Japan Diabetes Complications Study.
    Sone H; Mizuno S; Fujii H; Yoshimura Y; Yamasaki Y; Ishibashi S; Katayama S; Saito Y; Ito H; Ohashi Y; Akanuma Y; Yamada N;
    Diabetes Care; 2005 Jun; 28(6):1463-71. PubMed ID: 15920069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Added value of different metabolic syndrome definitions for predicting cardiovascular disease and mortality events among elderly population: Tehran Lipid and Glucose Study.
    Mozaffary A; Bozorgmanesh M; Sheikholeslami F; Azizi F; Eskandari F; Hadaegh F
    Eur J Clin Nutr; 2014 Jul; 68(7):853-8. PubMed ID: 24865481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between cumulative metabolic risk exposure and cardiovascular disease: a nationwide cohort of over 3.6 million young adults.
    Lee H; Rhee TM; Park HE; Han K; Choi SY
    Eur J Prev Cardiol; 2024 Aug; 31(10):1288-1300. PubMed ID: 38421612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between metabolic score for insulin resistance and cardiovascular disease mortality in patients with rheumatoid arthritis: evidence from the NHANES 1999-2018.
    Zhou Y; Gao J
    Front Endocrinol (Lausanne); 2024; 15():1444800. PubMed ID: 39345880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The predictive value of metabolic syndrome for cardiovascular and all-cause mortality: Tehran Lipid and Glucose Study.
    Amouzegar A; Mehran L; Hasheminia M; Kheirkhah Rahimabad P; Azizi F
    Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27155315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of metabolic syndrome and constitutional medicine for the prediction of cardiovascular disease.
    Cho NH; Kim JY; Kim SS; Shin C
    Diabetes Metab Syndr; 2013; 7(4):226-32. PubMed ID: 24290090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome and subsequent risk of type 2 diabetes and cardiovascular disease in elderly women: Challenging the current definition.
    Dragsbæk K; Neergaard JS; Laursen JM; Hansen HB; Christiansen C; Beck-Nielsen H; Karsdal MA; Brix S; Henriksen K
    Medicine (Baltimore); 2016 Sep; 95(36):e4806. PubMed ID: 27603394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.